Moreover, these findings may inform the development of personalized chemotherapy strategies, such as selecting optimal anticancer agents or adjusting dosages based on ABCG2 haplotype status, and contribute to novel approaches to overcome ABCG2-mediated drug resistance in cancer treatments. The gene discussed is ABCG2; the disease is cancer.